Given the fact that our results confirmed that ERβ promoted IL6 expression via the MAPK/ERK and PI3K/AKT signaling pathways in lung cancer cells with E2 administration, we next tested whether there exists a positive feedback loop between IL6 and ERβ in lung cancer. Here, AKT1 is linked to lung cancer.